1. Home
  2. TLSA vs STKS Comparison

TLSA vs STKS Comparison

Compare TLSA & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

N/A

Current Price

$1.15

Market Cap

145.1M

Sector

Health Care

ML Signal

N/A

Logo The ONE Group Hospitality Inc.

STKS

The ONE Group Hospitality Inc.

N/A

Current Price

$1.58

Market Cap

52.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
TLSA
STKS
Founded
2013
2004
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
145.1M
52.7M
IPO Year
2017
2011

Fundamental Metrics

Financial Performance
Metric
TLSA
STKS
Price
$1.15
$1.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
★ $7.97
$4.45
AVG Volume (30 Days)
★ 545.0K
18.3K
Earning Date
05-01-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $805,722,000.00
Revenue This Year
N/A
$0.77
Revenue Next Year
N/A
$7.93
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 19.66
52 Week Low
$0.76
$1.50
52 Week High
$2.33
$2.91

Technical Indicators

Market Signals
Indicator
TLSA
STKS
Relative Strength Index (RSI) 59.09 37.40
Support Level $0.90 N/A
Resistance Level $1.20 $2.03
Average True Range (ATR) 0.09 0.07
MACD 0.02 0.00
Stochastic Oscillator 94.69 23.81

Price Performance

Historical Comparison
TLSA
STKS

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

About STKS The ONE Group Hospitality Inc.

The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through three segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.

Share on Social Networks: